Ketamine in acute phase of severe traumatic brain injury “an old drug for new uses?”
Open Access
- 6 January 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Critical Care
- Vol. 25 (1), 1-7
- https://doi.org/10.1186/s13054-020-03452-x
Abstract
Maintaining an adequate level of sedation and analgesia plays a key role in the management of traumatic brain injury (TBI). To date, it is unclear which drug or combination of drugs is most effective in achieving these goals. Ketamine is an agent with attractive pharmacological and pharmacokinetics characteristics. Current evidence shows that ketamine does not increase and may instead decrease intracranial pressure, and its safety profile makes it a reliable tool in the prehospital environment. In this point of view, we discuss different aspects of the use of ketamine in the acute phase of TBI, with its potential benefits and pitfalls.Keywords
This publication has 52 references indexed in Scilit:
- Sedation in Traumatic Brain InjuryEmergency Medicine International, 2012
- Sedation for critically ill adults with severe traumatic brain injury: A systematic review of randomized controlled trials*Critical Care Medicine, 2011
- Moderate and severe traumatic brain injury in adultsThe Lancet Neurology, 2008
- Ketamine for analgosedative therapy in intensive care treatment of head-injured patientsActa Neurochirurgica, 1996
- Ketamine-induced Apnea in Patients with Increased intracranial PressureAnesthesiology, 1972
- The Effects of Ketamine on Cerebral Circulation and Metabolism in ManAnesthesiology, 1972
- Increased Cerebrospinal Fluid Pressure after KetamineAnesthesiology, 1972
- Ketamine in neurosurgical proceduresThe Lancet, 1971
- Cerebrospinal-fluid Pressure during Dissociative Anesthesia with KetamineAnesthesiology, 1971